CH Biotech R&D Co., Ltd.
Research CH Biotech R&D Co., Ltd. (6534.TW) on Bullrun: market cap TWD 9.38B, P/E 16.0, dividend yield 6.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6534.TW
- ExchangeTW
- CountryTaiwan
- SectorBasic Materials
- IndustryAgricultural Inputs
- CurrencyTWD
- Market capTWD 9.38B
- P/E16.0
- Dividend yield6.2%
- Financial periodQ2 2026
- RevenueTWD 459.43M
- Net incomeTWD 151.13M
- Free cash flowTWD 404.17M
- Gross margin84.9%
Valuation Snapshot
latest market cap is TWD 9.38B; P/E is 16.0; dividend yield is 6.2%.
Peer valuation comparison
Latest P/E is 16.02x versus a Basic Materials sector median of 14.77x (8.5% above).
Latest dividend yield is 6.23% versus a Basic Materials sector median of 2.67% (133.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 9.38B | 16.0 | 5.7% | 5.31 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 5.31 TWD, yield 6.2%.
About CH Biotech R&D Co., Ltd.
CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers, biostimulants, and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan.
ETFs that hold CH Biotech R&D Co., Ltd.
US-listed ETFs
CH Biotech R&D Co., Ltd. is held by one US-listed ETF, going by the latest portfolio it filed with the SEC:
| ETF | Weight | Fee |
|---|---|---|
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.01% | 0.65% |
Portfolios as filed with the SEC on Form N-PORT, dated June 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is CH Biotech R&D Co., Ltd.'s market cap?
CH Biotech R&D Co., Ltd.'s market capitalization is TWD 9.38B.
What is CH Biotech R&D Co., Ltd.'s P/E ratio?
CH Biotech R&D Co., Ltd.'s price-to-earnings (P/E) ratio is 16.0.
Does CH Biotech R&D Co., Ltd. pay a dividend?
CH Biotech R&D Co., Ltd. has a dividend yield of 6.2%.
What does CH Biotech R&D Co., Ltd. do?
CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers, biostimulants, and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan.